Temazepam
| Temazepam | |
|---|---|
| Salts [] | |
|---|---|
| Temazepam hydrochloride | |
| Temazepam sulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 300.74 g/mol [1] |
| Melting point | 119-121 °C [1] |
| Solubility | 164 mg/L [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H13ClN2O2 |
| IUPAC name | 7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one |
| SMILES | CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3 |
| InChI | InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3 |
| InChIKey | SEQDDYPDSLOBDC-UHFFFAOYSA-N |
| CAS number | 846-50-4 |
| UNII | CHB1QD2QSS |
| PubChem CID | 5391 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 8–20 hours |
| Duration of action | ≤8 hours |
| Metabolism | Liver |
| Excretion | Kidney |
| Routes of administration | By mouth |
| Dependence liability | High[3] |
| Toxicity [] | |
|---|---|
| LD50 | Mice: - oral: 1963 mg/kg [1] |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Threshold | 1 - 2.8000000000000003 |
| Light | 2.8000000000000003 - 20 |
| Common | 20 - 30 |
| Strong | 30 - 60 |
| Heavy | 60 |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Temazepam (also known as Restoril, Hydroxydiazepam, Methyloxazepam, Oxydiazepam, Normison, N-Methyloxazepam, 3-Hydroxydiazepam, Temaz, Nocturne or Temtabs) is a steroid substance of the aniline and benzodiazepine class.
Chemistry
Salts []
Stereochemistry []
Temazepam is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Temazepam matches Lipinski's rule of five.Reagents
There are currently 9 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | faint orange/brownish | |
| Liebermann | no color change | |
| Froehde | no color change | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Morris | green | |
| Zimmermann | no change / faint yellow |
Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- benzodiazepine derivatives (N05CD)
- temazepam (N05CD07)
MeSH Classification
Mechanism of action []
Gamma-Aminobutyric acid (GABA) is considered the principal inhibitory neurotransmitter in the human body. When GABA binds to GABA(a) receptors found in neuron synapses, chloride ions are conducted across neuron cell membranes via an ion channel in the receptors. With enough chloride ions conducted, the local, associated neuron membrane potentials are hyperpolarized - making it more difficult or less likely for action potentials to fire, ultimately resulting in less excitation of the neurons. Subsequently, benzodiazepines like temazepam can bind to benzodiazepine receptors that are components of various varieties of GABA(a) receptors. This binding acts to enhance the effects of GABA by increasing GABA affinity for the GABA(a) receptor, which ultimately enhances GABA ligand binding at the receptors. This enhanced ligand binding of the inhibitory neurotransmitter GABA to the receptors increases the aforementioned chloride ion conduction (perhaps reportedly via an increase in the frequency of the chloride channel opening), resulting in a hyperpolarized cell membrane that prevents further excitation of the associated neuron cells. Combined with the notion that such benzodiazepine receptor associated GABA(a) receptors exist both peripherally and in the CNS, this activity consequently facilitates various effects like sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| GABRA1 | shared target | 5 |
|---|---|---|
| GABRA2 | shared target | 5 |
| GABRA3 | shared target | 5 |
| GABRA4 | shared target | 5 |
| GABRA5 | shared target | 5 |
| GABRA6 | shared target | 5 |
| GABRB1 | shared target | 5 |
| GABRB2 | shared target | 5 |
| GABRB3 | shared target | 5 |
| GABRD | shared target | 5 |
| GABRE | shared target | 5 |
| GABRG1 | shared target | 5 |
| GABRG2 | shared target | 5 |
| GABRG3 | shared target | 5 |
| GABRP | shared target | 5 |
| GABRQ | shared target | 5 |
Medical side effects []
84 side effects listed on drug labels in SIDER 4.1 (temazepam).
- Somnolence
- Headache
- Asthenia
- Fatigue
- Nervousness
- Tension
- Dizziness
- Syncope
- Lethargy
- Nausea
- Hangover
- Anxiety
- Depression
- Diarrhoea
- Dry mouth
- Abdominal discomfort
- Gastrointestinal tract irritation
- Euphoric mood
- Confusional state
- Feeling abnormal
- Vision blurred
- Nightmare
- Vertigo
- Aggression
- Agranulocytosis
- Alopecia
- Amnesia
- Decreased appetite
- Apnoea
- Ataxia
- Back pain
- Coma
- Constipation
- Diplopia
- Dysarthria
- Slurred speech
- Osteoarthritis
- Dyspnoea
- Hallucination
- Hostility
- Hyperhidrosis
- Hypersensitivity
- Hyponatraemia
- Hypotension
- Body temperature decreased
- Hypothermia
- Inappropriate antidiuretic hormone secretion
- Irritability
- Jaundice
- Muscle spasms
- Leukocytosis
- Nystagmus
- Palpitations
- Proteinuria
- Protein urine present
- Pruritus
- Sciatica
- Convulsion
- Sleep apnoea syndrome
- Sleep disorder
- Shock
- Loss of consciousness
- Tachycardia
- Thrombocytopenia
- Tremor
- Vomiting
- Agitation
- Excitement
- Depressed level of consciousness
- Rash macular
- Disorientation
- Extrapyramidal disorder
- Respiratory depression
- Pulmonary function test decreased
- Abnormal dreams
- Vivid dreams
- Erectile dysfunction
- Balance disorder
- Suicidal ideation
- Disinhibition
- Visual impairment
- Obstructive airways disorder
- Blood alkaline phosphatase increased
- Ageusia
Indications
- Insomnia
- Terminal insomnia
Subjective effects []
Experience reports
Legal status []
- Australia: Temazepam is a Schedule 4.
- Brazil: Temazepam is a B1.[4]
- Canada: Temazepam is a Schedule IV.[5]
- Germany: Temazepam is Prescription only /Anlage III.
- New Zealand: Temazepam is a Class C5.[6]
- United Kingdom: Temazepam is a Class C / Schedule 3 under the "Misuse of Drugs Act 1971".[7][8]
- United States: Temazepam is a Schedule IV under the "Controlled Substances Act".[9]
- United Nations: Temazepam is a Psychotropic Schedule IV.
- Other: Temazepam is a SE: Förteckning IV, In general: ℞ (Prescription only).[10]
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5391, Temazepam. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5391
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Temazepam. UNII: CHB1QD2QSS. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CHB1QD2QSS
Temazepam. www.drugbank.ca. https://www.drugbank.ca/drugs/DB00231
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Temazepam Product information. Health Canada. 25 April 2012. https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43372
Normison (temazepam) Datasheet. Medsafe NZ. https://www.medsafe.govt.nz/profs/datasheet/n/normisontab.pdf
. 1971.
. 2001.
Restoril- temazepam capsule. DailyMed. 11 February 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc56f7fd-1aaf-48ff-8aa7-d467e59e1015
Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 13:51:12 |
| drugspro | ok | 2026-11-20 13:51:08 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 13:51:08 |
| gsrs | ok | 2026-11-20 13:51:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014376) | 2026-11-20 13:51:08 |
| kegg | ok | 2026-11-20 13:51:09 |
| pubchem | ok | 2026-11-20 13:51:06 |
| ok | 2026-11-20 13:51:08 | |
| sider | ok | 2026-11-20 13:51:08 |
| structure | ok | 2026-11-20 13:51:08 |
| wikipedia | ok | 2026-11-20 13:51:08 |